Lionco Pharmaceutical Group Co., Ltd.SSE: 603669

(603669)"Lionco Pharmaceutical Group Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes

· Issued by Lionco Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603669 · · 2 pages · Chinese

Summary by 6ix AI

Lionco Pharmaceutical Group Co., Ltd. announced the results of its convertible bonds conversion and the resulting share changes. The announcement details the amount converted and the number of shares created from the conversion of the bonds. It also outlines the total amount of convertible bonds that remain unconverted as of the reporting date. The filing includes information on the company's share capital changes due to the conversion process.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603669lionco-pharmaceutical-group-co-ltdannouncement-on-conversion-results-of-convertible-bonds-and-share-changes

Release

Announcement on Conversion Results of Convertible Bonds and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Lionco Pharmaceutical Group Co., Ltd. on 6ix

Story so far

Earlier from Lionco Pharmaceutical

All Lionco Pharmaceutical news releases